Drugmakers Secure $2.1 Billion Vaccine Deal With U.S.

Two drugmakers secured a $2.1 billion dollar deal with the U.S. government to produce millions of doses of an experimental coronavirus vaccine. Dr. Peter Pitts, President of the Center for Medicine in the Public Interest, joined Cheddar to discuss.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.